http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103160464-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f484eea2cffe6dc099b47cdeeb981859 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078 |
| filingDate | 2013-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe3a43cdbd0cb6dc00da1c1a41536eec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79828ca7b665ff1fe75ac063a8666df1 |
| publicationDate | 2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103160464-A |
| titleOfInvention | Preparation method and kit for effector lymphocyte capable of rapidly proliferating, kit and application of kit |
| abstract | The invention provides a preparation method for effector lymphocyte capable of rapidly proliferating. The preparation method comprises the working procedure of culturing the effector lymphocyte capable of rapid proliferating under the immobilization condition that an FMS-like tyrosine kinase 3 ligand exists alone or coexists with an anti-human CD3 antibody, wherein the amplification multiple of the effector lymphocyte is above 114. The invention also provides a kit containing a kit product obtained through the method and application of the kit in preparation of the effector lymphocyte capable of rapidly proliferating. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108690829-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108690829-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105176928-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104357389-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105176928-A |
| priorityDate | 2013-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.